The trajectory of companies tied to blockbuster drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the patent expiration in key territories has introduced substantial uncertainty . Investors are now grappling with the effect of